Therapeutic Vaccine Market Size, Demand & Opportunity Analysis By Type (Infectious Disease Vaccines, Addiction Vaccines, Neurological disease vaccines, Autoimmune Disease Vaccines)

Research Nester has recently announced new market demand assessment research titled “Therapeutic Vaccine Market – Global Demand Analysis & Opportunity Outlook 2021. The global market study provides a granular data and in-depth analysis on the current and future market situations that are crucial for the existing &new players in the market. The industry research is based on key factors like demand & supply analysis, commercial activities, research investments, pricing analysis, government initiatives & guidelines, driving forces in the market, roadblocks and segmentation based on the product viability.

Therapeutic Vaccines are the vaccines that give immunity to the body to act against various infectious diseases such as: HIV, Cancer, Hepatitis C, Neurological Disease, Parkinson’s disease, Alzheimer’s disease and other infectious diseases. Growing at a CAGR of 33.8%, the global market of therapeutic vaccines is anticipated to reach USD 4.84 Billion over the forecasted period from 2015-2020.

At present, North America is the biggest market for therapeutic vaccine and expected to continue its dominance in near future. The North America market was estimated USD 79,283 Million in 2014 which is projected to reach USD 147,801 Million by 2021. Asia-Pacific Region is anticipated to grow at a high rate owning to increase in aging population over the forecasted years.

Escalating chronic diseases, expanded government funds for the vaccines development, great penetration of healthcare insurance in almost every country across the globe, rising medical tourism especially in Asia etc. are few of the key drivers for the global market of therapeutic vaccines. However, high cost of vaccines, generic drugs usage in developing countries and complex policies made by the government are projected to hamper the growth of global market of therapeutic vaccines.

Analysis By Types

  • Allogeneic vaccines
  • Autologous vaccines

Key Players

  • Cytos Biotechnology
  • Antigenics
  • Bavarian Nordic
  • Celldex Therapeutics
  • Affiris
  • Argos Therapeutics
  • Biovest International
  • Celtic Pharma
  • Cel-Sci
  • Curevac

Regions Studied:

  • North America (United States / U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia, Poland, Rest of Eastern Europe)
  • Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
  • Rest of World

To know more on coverage, click on the link below:-

http://www.researchnester.com/reports/global-therapeutic-vaccines-market-analysis-opportunity-outlook-2021/108

Contact Us:
Ajay Daniel
Email: ajay.daniel@researchnester.com
Phone : U.S. +1 646 586 9123
U.K. +44 203 608 5919

Leave a Reply

Your email address will not be published. Required fields are marked *